H. Jones et al., RISPERIDONE IS ASSOCIATED WITH BLUNTING OF D-FENFLURAMINE EVOKED SEROTONERGIC RESPONSES IN SCHIZOPHRENIA, International clinical psychopharmacology, 13(5), 1998, pp. 199-203
The high 5-HT affinity of some atypical antipsychotic agents is though
t to contribute to their clinical efficacy. We examined central 5-HT r
esponses in two groups of ten schizophrenic patients by measuring seru
m prolactin and cortisol responses to the neuroendocrine challenge D-f
enfluramine. One group of patients with schizophrenia was tested after
a 2-week neuroleptic free period. A similar group were tested after a
mean of 12 weeks treatment with the atypical antipsychotic risperidon
e. A significant elevation of baseline serum prolactin levels, consist
ent with dopaminergic antagonism was seen after risperidone treatment.
Significantly reduced 5-HT mediated serum prolactin responses were se
en in risperidone treated patients. D-fenfluramine evoked serum prolac
tin responses were positively correlated with positive but not negativ
e schizophrenic symptoms for all 20 patients. Risperidone treatment wa
s associated with a significant functional in-vivo 5-HT antagonism sim
ilar to clozapine. 5-HT antagonism may contribute to the efficacy of r
isperidone against positive schizophrenic symptoms. Int Clin Psychopha
rmacol 13:199-203 (C) 1998 Lippincott Williams & Wilkins.